(2), RVF post cardiac surgery (1), RVF post LVAD implantation (2) and RVF post acute myocardial infarction (1). All patients were in cardiogenic shock prior to Impella RP implant.The percutaneous implant of the device was feasible and successful in 100% of the patients. The support time ranged from 1 to 9 days, with more than 60% of the patients being supported for longer than 4 days (median of 6.5 days) and explanted upon RV recovery. The average flow was 3.9 L/min. Overall thirty-day survival was 83%. Conclusions: A novel percutaneous right ventricular assist device has been developed. The design was enhanced after the first implant to improve torque-ability and push-ability which resulted in an ease of placement for the subsequent patients. The preliminary clinical experience is very encouraging and further evaluation is ongoing.
TCT-373

Impact of Epicardial Fat Volume on Coronary Artery Disease in Symptomatic Patients with a Zero Calcium Score
Toyohashi Heart Center, Toyohashi, Japan Background: Prevalence of coronary artery disease (CAD) is not fully elucidated in symptomatic patients with a zero calcium score (CS) by computed tomography (CT). Epicardial fat volume (EFV) has been suggested as a predictor of CAD. The aim of our study is to investigate the prevalance of CAD and the impact of EFV on CAD in symptomatic patients with a zero CS with multislice CT (MSCT). Methods: In this study, 1308 consecutive symptomatic patients who underwent 64-slice MSCT with a zero CS were evaluated. EFV was quantified with CS data sets. Presence of an obstructive plaque (diameter stenosisϾ50%) and a CT-derived vulnerable plaque, which was defined as a plaque with remodeling indexϾ1.10 and mean CT density value Ͻ30Hounsfield Units, was assessed with a CT coronary angiography. Results: Obstructive plaques were detected in 86 patients (7%) and CT-derived vulnerable plaques in 63 (5%). EFV was larger in patients with obstructive plaques than no plaque (124.3Ϯ43.2cm3 vs. 95.1Ϯ40.3cm3; pϽ0.01). Patients with CT-derived vulnerable plaques had a greater amount of EFV than no plaque (133.0Ϯ40.2cm3 vs. 95.1Ϯ40.3cm3; pϽ0.01). Multivariate analysis revealed EFV as a predictor of the presence of an obstructive and a CT-derived vulnerable plaque (per 10cm3; Odds ratio (OR) 1.10; 95% confidence interval (CI), 1.04-1.16; pϽ0.01 and OR 1.19; 95% CI, 1.12-1.27; pϽ0.01). The combination of EFV and Framingham risk score (FRS) resulted in an area under the receiver-operating characteristic curve for prediction of obstructive and CT-derived vulnerable plaque of 0.75 and 0.75, which was significantly higher than 0.68 and 0.64 for FRS alone (pϭ 0.02 and pϽ0.01). Conclusions: A zero CS doesn't exclude CAD and EFV can be a useful marker of CAD in symptomatic zero CS patients. 
TCT-374
Long-term Survival and Neurological Outcome of In-hospital Cardiac Arrest Patients Rescued by Extracorporeal Cardiopulmonary Resuscitation
Background:
The immediate clinical benefit of extracorporeal cardiopulmonary resuscitation (E-CPR) has been proved in short-term follow-up studies. However, it has been not known whether the benefit of E-CPR persists for more than 1 year. We compared the long-term outcomes of patients who received E-CPR or conventional CPR (C-CPR) and investigated the clinical characteristics of long-term survivors. Methods: We analyzed a total of 406 adult in-hospital cardiac arrest victims received CPR for more than 10 minutes from 2003 to 2009. The long-term survival and neurological outcome of E-CPR (nϭ85) and C-CPR (nϭ321) were compared using propensity score-matched analysis. Results: The 2-year survival with minimal neurological impairment was 4-fold higher in E-CPR group than C-CPR group (23.5% versus 5.9%, hazard ratio (HR) ϭ 0.57, 95% confidence interval (CI) ϭ 0.43-0.75, pϽ0.001) by unadjusted analysis. After propensityscore matching, it was still 4-fold higher in E-CPR group than C-CPR group (20.0% versus 5. 0%, HRϭ0.53, pϭ0.002 ). In the E-CPR group, the independent predictors associated with minimal neurological impairment were age Յ65 years (HRϭ0.46; 95% CIϭ0.26-0.81; pϭ0.008), CPR duration Յ35 min (HRϭ0.37; 95% CIϭ0.18-0.76; pϭ0.007), and subsequent cardiovascular intervention including coronary intervention or cardiac surgery (HRϭ0.36; 95% CIϭ0.18-0.68; pϭ0.002).
Conclusions:
The initial survival benefit of E-CPR for cardiac arrest patients was maintained at 2 year.
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Optimizing 
